Small changes in molecular structure often change absorption, effectiveness, and stability
However, driven by shifts in dietary patterns and rising obesity rates, its incidence and prevalence are steadily increasing, with the disease increasingly manifesting in younger individuals ( Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a novel class of antidiabetic agents that activate the GLP-1 receptor to stimulate insulin secretion and inhibit glucagon secretion in a glucose-dependent manner, delay gastric emptying, thereby controlling blood glucose and promoting weight loss ( Previous meta-analyses have primarily pooled the cardiovascular effects of GLP-1 RAs in patients with T2DM ( This study performed a systematic review and meta-analysis to evaluate the effects of subcutaneous vs
Semaglutidea GLP-1 (glucagon-like peptide-1) receptor agonist that helps manage blood sugar and appetiteis typically administered through a small needle into the fatty tissue
Jerusalem artichokes and chicory root contain high levels of inulin, a particularly effective prebiotic fiber
Patel and Saadabadi, 2025)
Parente believes the jury is still out on the future of GLP-1s
.png)
